Post-streptococcal glomerulonephritis epidemiology and demographics: Difference between revisions
No edit summary |
|||
| (11 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
The incidence of [[post-streptococcal glomerulonephritis]] is approximately 9.5 to 28.5 per 100,000 individuals worldwide. The case-fatality rate of [[post-streptococcal glomerulonephritis]] is approximately 2 percent in India and 0.08 percent in Turkey. It commonly affects children with age between 5 to 12 years. The incidence of [[post-streptococcal glomerulonephritis]] increases in older people age greater than 60 years. It commonly affects children with age between 5 to 12 years. Men are more commonly affected by [[post-streptococcal glomerulonephritis]] than women. The majority of [[post-streptococcal glomerulonephritis]] cases are reported in developing countries. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
The incidence of post-streptococcal glomerulonephritis is approximately 9.5 to 28.5 per 100,000 individuals worldwide.<ref name="pmid16253886">{{cite journal |vauthors=Carapetis JR, Steer AC, Mulholland EK, Weber M |title=The global burden of group A streptococcal diseases |journal=Lancet Infect Dis |volume=5 |issue=11 |pages=685–94 |date=November 2005 |pmid=16253886 |doi=10.1016/S1473-3099(05)70267-X |url=}}</ref> | *The incidence of [[post-streptococcal glomerulonephritis]] is approximately 9.5 to 28.5 per 100,000 individuals worldwide.<ref name="pmid16253886">{{cite journal |vauthors=Carapetis JR, Steer AC, Mulholland EK, Weber M |title=The global burden of group A streptococcal diseases |journal=Lancet Infect Dis |volume=5 |issue=11 |pages=685–94 |date=November 2005 |pmid=16253886 |doi=10.1016/S1473-3099(05)70267-X |url=}}</ref> | ||
===Case-fatality | ===Case-fatality rate=== | ||
* | *The case-fatality rate of post-streptococcal glomerulonephritis is approximately 2 percent in India and 0.08 percent in Turkey.<ref name="pmid21371205">{{cite journal |vauthors=Jackson SJ, Steer AC, Campbell H |title=Systematic Review: Estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis |journal=Trop. Med. Int. Health |volume=16 |issue=1 |pages=2–11 |date=January 2011 |pmid=21371205 |doi=10.1111/j.1365-3156.2010.02670.x |url=}}</ref> | ||
===Age=== | ===Age=== | ||
The incidence of post-streptococcal glomerulonephritis increases in older people age greater than 60 years | *The incidence of [[post-streptococcal glomerulonephritis]] increases in older people age greater than 60 years. | ||
*It commonly affects [[children]] with age between 5 to 12 years. | |||
===Race=== | ===Race=== | ||
*There is no racial predilection to [ | *There is no racial predilection to [[post-streptococcal glomerulonephritis]]. | ||
===Gender=== | ===Gender=== | ||
*Men are more commonly affected by post-streptococcal glomerulonephritis than women. | |||
===Region=== | ===Region=== | ||
*The majority of | *The majority of post-streptococcal glomerulonephritis cases are reported in developing countries.<ref name="pmid18667731">{{cite journal |vauthors=Rodriguez-Iturbe B, Musser JM |title=The current state of poststreptococcal glomerulonephritis |journal=J. Am. Soc. Nephrol. |volume=19 |issue=10 |pages=1855–64 |date=October 2008 |pmid=18667731 |doi=10.1681/ASN.2008010092 |url=}}</ref> | ||
=== | |||
==References== | ==References== | ||
Latest revision as of 19:51, 14 June 2018
|
Post-streptococcal glomerulonephritis Microchapters |
|
Differentiating Post-streptococcal glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Post-streptococcal glomerulonephritis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis epidemiology and demographics |
|
FDA on Post-streptococcal glomerulonephritis epidemiology and demographics |
|
CDC on Post-streptococcal glomerulonephritis epidemiology and demographics |
|
Post-streptococcal glomerulonephritis epidemiology and demographics in the news |
|
Blogs on Post-streptococcal glomerulonephritis epidemiology and demographics |
|
Directions to Hospitals Treating Post-streptococcal glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
The incidence of post-streptococcal glomerulonephritis is approximately 9.5 to 28.5 per 100,000 individuals worldwide. The case-fatality rate of post-streptococcal glomerulonephritis is approximately 2 percent in India and 0.08 percent in Turkey. It commonly affects children with age between 5 to 12 years. The incidence of post-streptococcal glomerulonephritis increases in older people age greater than 60 years. It commonly affects children with age between 5 to 12 years. Men are more commonly affected by post-streptococcal glomerulonephritis than women. The majority of post-streptococcal glomerulonephritis cases are reported in developing countries.
Epidemiology and Demographics
Incidence
- The incidence of post-streptococcal glomerulonephritis is approximately 9.5 to 28.5 per 100,000 individuals worldwide.[1]
Case-fatality rate
- The case-fatality rate of post-streptococcal glomerulonephritis is approximately 2 percent in India and 0.08 percent in Turkey.[2]
Age
- The incidence of post-streptococcal glomerulonephritis increases in older people age greater than 60 years.
- It commonly affects children with age between 5 to 12 years.
Race
- There is no racial predilection to post-streptococcal glomerulonephritis.
Gender
- Men are more commonly affected by post-streptococcal glomerulonephritis than women.
Region
- The majority of post-streptococcal glomerulonephritis cases are reported in developing countries.[3]
References
- ↑ Carapetis JR, Steer AC, Mulholland EK, Weber M (November 2005). "The global burden of group A streptococcal diseases". Lancet Infect Dis. 5 (11): 685–94. doi:10.1016/S1473-3099(05)70267-X. PMID 16253886.
- ↑ Jackson SJ, Steer AC, Campbell H (January 2011). "Systematic Review: Estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis". Trop. Med. Int. Health. 16 (1): 2–11. doi:10.1111/j.1365-3156.2010.02670.x. PMID 21371205.
- ↑ Rodriguez-Iturbe B, Musser JM (October 2008). "The current state of poststreptococcal glomerulonephritis". J. Am. Soc. Nephrol. 19 (10): 1855–64. doi:10.1681/ASN.2008010092. PMID 18667731.